The Norman/Clayman Endocrine Institute announced that new patient referrals for thyroid, parathyroid and adrenal cancer tumor surgeries are at record levels. Surgery for endocrine tumors therefore appears pandemic-proof, while other hospitals fear for elective surgical delays due to the Covid delta variant surge.

document preview